Relationship between hypoxia and response to antiangiogenic therapy in metastatic colorectal cancer

Autor Ulivi, Paola, Marisi, Giorgia, Passardi, Alessandro
Vydáno v Oncotarget (2016)

Special Issue on Basic and Translational Research in Colorectal Cancer

Autor Ulivi, Paola, Scarpi, Emanuela, Passardi, Alessandro
Vydáno v Int J Mol Sci (2019)

Molecular and Translational Research on Colorectal Cancer

Autor Passardi, Alessandro, Scarpi, Emanuela, Ulivi, Paola
Vydáno v Int J Mol Sci (2020)

Special Issue on Molecular and Translational Research on Colorectal Cancer 2.0

Autor Passardi, Alessandro, Scarpi, Emanuela, Ulivi, Paola
Vydáno v Int J Mol Sci (2021)

Immune Checkpoints as a Target for Colorectal Cancer Treatment

Autor Passardi, Alessandro, Canale, Matteo, Valgiusti, Martina, Ulivi, Paola
Vydáno v Int J Mol Sci (2017)

Discrepancies between VEGF −1154 G>A Polymorphism Analysis Performed in Peripheral Blood Samples and FFPE Tissue

Autor Marisi, Giorgia, Passardi, Alessandro, Calistri, Daniele, Zoli, Wainer, Amadori, Dino, Ulivi, Paola
Vydáno 2014

Detection of KRAS mutant alleles in circulating cell-free tumor DNA in colorectal cancer patients resistant to cetuximab

Autor Del Re, Marzia, Ulivi, Paola, Passardi, Alessandro, Zoli, Wainer, Danesi, Romano, Amadori, Dino
Vydáno 2014

Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?

Autor Molinari, Chiara, Marisi, Giorgia, Passardi, Alessandro, Matteucci, Laura, De Maio, Giulia, Ulivi, Paola
Vydáno v Int J Mol Sci (2018)

EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab

Autor CHIADINI, ELISA, SCARPI, EMANUELA, PASSARDI, ALESSANDRO, CALISTRI, DANIELE, VALGIUSTI, MARTINA, SARAGONI, LUCA, ZOLI, WAINER, AMADORI, DINO, ULIVI, PAOLA
Vydáno v Oncol Lett (2015)

Instability of Non-Standard Microsatellites in Relation to Prognosis in Metastatic Colorectal Cancer Patients

Autor Pirini, Francesca, Pasini, Luigi, Tedaldi, Gianluca, Scarpi, Emanuela, Marisi, Giorgia, Molinari, Chiara, Calistri, Daniele, Passardi, Alessandro, Ulivi, Paola
Vydáno v Int J Mol Sci (2020)

Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer

Autor Ulivi, Paola, Canale, Matteo, Passardi, Alessandro, Marisi, Giorgia, Valgiusti, Martina, Frassineti, Giovanni Luca, Calistri, Daniele, Amadori, Dino, Scarpi, Emanuela
Vydáno v Int J Mol Sci (2018)

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

Autor Maltoni Roberta, Nanni Oriana, Zumaglini Federica, Milandri Carlo, Gianni Lorenzo, Zoli Wainer, Massa Ilaria, Passardi Alessandro, Frassineti Giovanni, Amadori Dino
Vydáno 2006-03-01

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

Autor Passardi, Alessandro, Massa, Ilaria, Zoli, Wainer, Gianni, Lorenzo, Milandri, Carlo, Zumaglini, Federica, Nanni, Oriana, Maltoni, Roberta, Frassineti, Giovanni Luca, Amadori, Dino
Vydáno 2006

Prolonged Pemetrexed Infusion Plus Gemcitabine in Refractory Metastatic Colorectal Cancer: Preclinical Rationale and Phase II Study Results

Autor Passardi, Alessandro, Fanini, Francesca, Turci, Livia, Foca, Flavia, Rosetti, Paola, Ruscelli, Silvia, Casadei Gardini, Andrea, Valgiusti, Martina, Dazzi, Claudio, Marangolo, Maurizio
Vydáno v Oncologist (2017)

Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer

Autor Rapposelli, Ilario Giovanni, Casadei-Gardini, Andrea, Vivaldi, Caterina, Bartolini, Giulia, Bernardini, Laura, Passardi, Alessandro, Frassineti, Giovanni Luca, Massa, Valentina, Cucchetti, Alessandro
Vydáno v Biomolecules (2021)

miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer

Autor Molinari, Chiara, Salvi, Samanta, Foca, Flavia, Teodorani, Nazario, Saragoni, Luca, Puccetti, Maurizio, Passardi, Alessandro, Tamberi, Stefano, Avanzolini, Andrea, Lucci, Enrico, Calistri, Daniele
Vydáno v Onco Targets Ther (2016)

Radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival

Autor Gardini, Andrea Casadei, Marisi, Giorgia, Canale, Matteo, Foschi, Francesco Giuseppe, Donati, Gabriele, Ercolani, Giorgio, Valgiusti, Martina, Passardi, Alessandro, Frassineti, Giovanni Luca, Scarpi, Emanuela
Vydáno v Onco Targets Ther (2018)

Low-dose taxotere enhances the ability of sorafenib to induce apoptosis in gastric cancer models

Autor Tesei, Anna, Leonetti, Carlo, Zupi, Gabriella, Scarsella, Marco, Brigliadori, Giovanni, Ulivi, Paola, Fabbri, Francesco, Arienti, Chiara, Amadori, Dino, Passardi, Alessandro, Silvestrini, Rosella, Zoli, Wainer
Vydáno 2011

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

Autor Zoli Wainer, Zumaglini Federica, Oliverio Giovanni, Pasquini Enzo, Dazzi Claudio, Dall'Agata Monia, Cecconetto Lorenzo, Passardi Alessandro, Nanni Oriana, Milandri Carlo, Frassineti Giovanni, Amadori Dino
Vydáno 2008-10-01

Impact of Pre-Treatment Lactate Dehydrogenase Levels on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer

Autor Passardi, Alessandro, Scarpi, Emanuela, Tamberi, Stefano, Cavanna, Luigi, Tassinari, Davide, Fontana, Annalisa, Pini, Sara, Bernardini, Ilaria, Accettura, Caterina, Ulivi, Paola, Frassineti, Giovanni Luca, Amadori, Dino
Vydáno v PLoS One (2015)